Bone Marrow Transplantation News

High-dose oral vitamin A prior to hematopoietic stem cell transplantation reduced the incidence of graft-versus-host disease with minimal toxicity, according to study data published in Blood.

Researchers have created a novel tool that predicts a person’s risk for cardiovascular complications after bone marrow transplantation.

More than 20% of patients with cancer participate in some form of clinical study, and that number is considered a “floor” estimate, according to study results published in Journal of Clinical Oncology.

Palliative care significantly improved quality of life among patients hospitalized for bone marrow transplant, according to results of a multicenter randomized trial.

New guidelines for vaccinating adults with solid or hematologic cancers detailed the importance of vaccination optimization, multidisciplinary coordination and vaccination of household members.

Myelodysplastic syndrome predominantly affects older adults, with median age of onset of 70 years.

A sequential chimeric antigen receptor T-cell therapy and haploidentical hematopoietic stem cell transplantation strategy conferred remissions in certain patients with relapsed or refractory CD7-positive hematologic cancers.

Matt Kalaycio, MD, FACP, has been elected chair of National Comprehensive Cancer Network’s board of directors.

Chronic graft-versus-host disease was associated with clinically meaningful quality of life impairment and symptom burden, making patient-reported outcomes an important prognostic marker, according to a study.

Among elderly patients with acute myeloid leukemia, survival outcomes for those who received an allogenic stem cell transplant have improved significantly over the past 2 decades, according to data published in Clinical Cancer Research.